Skip to main content
Drug Development
Our Pipeline
Evaluation Pipeline
Inaphaea BioLabs
Therapeutic areas
Partnering
Useful Links
News
Investors
Regulatory News
AIM Rule 26
Annual and Half Yearly Reports
Admission Document & Articles
Investments Calculator
Share Alerts
Share Series
Share price look-up
Analyst Research
About us
Board of Directors and Management Team
Scientific Advisory Board
Strategy and Vision
How we work
Working with us
Collaborative Pipeline
Contact us
Search
News
Breadcrumb
News
Category
Articles
Events and presentations
News
Press releases
Videos and audiocasts
News
Inaphaea BioLabs secures first external contract
19 Jul 2023
News
Meet the Inaphaea BioLabs team: Melissa Barr, Lead Scientist
5 Jul 2023
News
ValiRx news roundup: June 2023
3 Jul 2023
News
Meet the Inaphaea BioLabs team: Dr Dominic Lowen, Senior Scientist
29 Jun 2023
Events and presentations
ValiRx 2023 AGM
29 Jun 2023
News
ValiRx acquires scientific assets from Imagen Therapeutics
16 Jun 2023
Events and presentations
ValiRx Shareholder Q&A, MediCity, Nottingham, June 2023
15 Jun 2023
Videos and audiocasts
ValiRx Signs New Contract with the University of Barcelona
7 Jun 2023
Articles
Meet the ValiRx team: Dr Suzy Dilly
19 May 2023
News
2023 events round-up: ValiRx and Inaphaea BioLabs
16 May 2023
Articles
Meet the ValiRx team: Kumar Nawani
3 May 2023
News
ValiRx and Physiomics join forces to provide seamless data integration
26 Apr 2023
Articles
Meet the Inaphaea BioLabs team: Dr Andrew Carnegie
21 Apr 2023
News
Article by Dr Cathy Tralau-Stewart published by European Pharmaceutical Manufacturer
12 Apr 2023
Pagination
First page
First
Previous page
Previous
Page
1
Current page
2
Page
3
Page
4
Page
5
Page
6
Next page
Next
Last page
Last
